Category - News
FDA Appears to Be Granting Zombie Rare Pediatric Disease Designations Waiting for the Rare Pediatric Disease Priority Review Voucher Program to be Revived
HPM’s Larry Houck Presenting at WCF Opioid and Fentanyl Abuse Management Congress
Get Up To Speed on Medicare Inflation Rebates: HPM Issues Memorandum Summarizing CMS Final Rule; HPM and Riparian to Co-Host Webinar
Into the Ashtray: FDA’s Previous Proposal to Ban Menthol Cigarettes
Small Change: FDA’s Final Predetermined Change Control Plan (PCCP) Guidance Ditches ML and Adds Some Details, But Otherwise Sticks Closely to the Draft
What to Expect When you are Expecting…a Government Shutdown
DEA Pharmacy Decision Highlights Agency’s Thinking on Expert Credibility and Testimony, as well as Red Flag Resolution
Decades of LDT Tension Leads to an Epic Three-Hour Oral Argument